Enterprise Value
179.8M
Cash
43.8M
Avg Qtr Burn
-8.708M
Short % of Float
3.29%
Insider Ownership
55.70%
Institutional Own.
3.21%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 3 Data readout | ||
BIV201 Details Ascites | Phase 2b Data readout |